{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:32:09Z","timestamp":1772584329383,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhepr.2025.101558","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:59:37Z","timestamp":1755878377000},"page":"101558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world work productivity is impaired in people with metabolic dysfunction-associated steatotic liver disease in the USA"],"prefix":"10.1016","volume":"7","author":[{"given":"Shraddha","family":"Shinde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Rinella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2396-7356","authenticated-orcid":false,"given":"Mark L.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3083-3615","authenticated-orcid":false,"given":"David","family":"Schapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3901-7390","authenticated-orcid":false,"given":"Victoria","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Leith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4208-2871","authenticated-orcid":false,"given":"James","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-0088","authenticated-orcid":false,"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101558_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101558_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40273-022-01140-y","article-title":"The economic burden of non-alcoholic steatohepatitis: a systematic review","volume":"40","author":"Witkowski","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jhepr.2025.101558_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40271-020-00485-w","article-title":"Development of a patient-reported outcome measure for non-alcoholic steatohepatitis (NASH-CHECK): results of a qualitative study","volume":"14","author":"Doward","year":"2021","journal-title":"Patient"},{"key":"10.1016\/j.jhepr.2025.101558_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000203","article-title":"The prevalence and risk factors for cognitive impairment in obesity and NAFLD","volume":"7","author":"Wernberg","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101558_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/liv.15761","article-title":"Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: a cross-sectional study","volume":"44","author":"Wernberg","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101558_bib9","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & causes of NAFLD & NASH. www.niddk.nih.gov\/health-information\/liver-disease\/nafld-nash\/symptoms-causes [Accessed August 21, 2025]."},{"key":"10.1016\/j.jhepr.2025.101558_bib10","first-page":"378","article-title":"Diagnosis of nonalcoholic steatohepatitis without liver biopsy","volume":"13","author":"Madrazo","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib11","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s12325-019-00960-3","article-title":"A structured literature review of the epidemiology and disease burden of non-alcoholic steatohepatitis (NASH)","volume":"36","author":"Povsic","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.jhepr.2025.101558_bib12","first-page":"759","article-title":"Cirrhosis: diagnosis and management","volume":"100","author":"Smith","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jhepr.2025.101558_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100727","article-title":"The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study","volume":"27","author":"Hamid","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib14","article-title":"Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study","volume":"2","author":"O'Hara","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101558_bib15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/17474124.2021.1974295","article-title":"Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review","volume":"15","author":"Schattenberg","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib16","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.cgh.2021.11.004","article-title":"Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the Global Non-Alcoholic Steatohepatitis (NASH)\/Non-Alcoholic Fatty Liver Disease (NAFLD) Registry","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib17","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3748\/wjg.v25.i28.3669","article-title":"Importance of fatigue and its measurement in chronic liver disease","volume":"25","author":"Gerber","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101558_bib18","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/biomedicines9111697","article-title":"Non-alcoholic fatty liver disease (NAFLD) and potential links to depression, anxiety, and chronic stress","volume":"9","author":"Shea","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhepr.2025.101558_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12876-023-02726-2","article-title":"The burden of nonalcoholic steatohepatitis (NASH) in the United States","volume":"23","author":"Tapper","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101558_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhepr.2019.05.009","article-title":"The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: a real-world patient-reported outcomes study","volume":"1","author":"Balp","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101558_bib21","article-title":"Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis","volume":"2","author":"McSweeney","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101558_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/liv.14825","article-title":"Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: a cost-of-illness analysis","volume":"41","author":"Schattenberg","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101558_bib23","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","article-title":"Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes","volume":"39","author":"Anderson","year":"2023","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jhepr.2025.101558_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010352","article-title":"Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme","volume":"6","author":"Babineaux","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2025.101558_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/DMSO.S120101","article-title":"Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015","volume":"9","author":"Higgins","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jhepr.2025.101558_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cld.81","article-title":"Nonalcoholic fatty liver disease: definitions, risk factors, and workup","volume":"1","author":"Puri","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2025.101558_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jhepr.2025.101558_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol--a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.jhepr.2025.101558_bib29","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40744-019-0155-5","article-title":"A threshold of meaning for work disability improvement in psoriatic arthritis measured by the work productivity and activity impairment questionnaire","volume":"6","author":"Tillett","year":"2019","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jhepr.2025.101558_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41687-023-00552-4","article-title":"Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine","volume":"7","author":"Ford","year":"2023","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.jhepr.2025.101558_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1524-4733.2009.00542.x","article-title":"Construct validity of the Work Productivity and Activity Impairment questionnaire across informal caregivers of chronically ill older patients","volume":"12","author":"Giovannetti","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jhepr.2025.101558_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jdv.15098","article-title":"Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients","volume":"33","author":"Wu","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jhepr.2025.101558_bib34","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.cgh.2019.02.024","article-title":"Reduced patient-reported outcome scores associate with level of fibrosis in patients with nonalcoholic steatohepatitis","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib35","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2024.05.008","article-title":"Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD","volume":"81","author":"Gawrieh","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib36","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cgh.2022.04.014","article-title":"Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Ng","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101558_bib38","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.cgh.2018.12.016","article-title":"Health-related quality of life in nonalcoholic fatty liver disease associates with hepatic inflammation","volume":"17","author":"Huber","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib39","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.14309\/ajg.0000000000000375","article-title":"Patients with nonalcoholic steatohepatitis experience severe impairment of health-related quality of life","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101558_bib40","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cgh.2020.06.064","article-title":"Real-world burden of nonalcoholic steatohepatitis","volume":"19","author":"Geier","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101558_bib41","article-title":"The burden of non-alcoholic steatohepatitis: a systematic review of health-related quality of life and patient-reported outcomes","volume":"4","author":"Younossi","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101558_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.20517\/mtod.2024.70","article-title":"A comprehensive review of patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease","volume":"4","author":"Sapmaz","year":"2024","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.jhepr.2025.101558_bib43","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/oby.22508","article-title":"Neurocognitive deficits in a cohort with class 2 and class 3 obesity: contributions of type 2 diabetes and other comorbidities","volume":"27","author":"Fernando","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.jhepr.2025.101558_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000541696","article-title":"The link between metabolic syndrome and the brain","volume":"106","author":"Zouridis","year":"2024","journal-title":"Digestion"},{"key":"10.1016\/j.jhepr.2025.101558_bib45","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.21037\/jtd-24-1322","article-title":"Prevalence of excessive daytime sleepiness (EDS) and its association with quality of life in patients with obstructive sleep apnea (OSA): data from a sleep-center in Shenzhen, a single-center cross-sectional study","volume":"16","author":"Tang","year":"2024","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jhepr.2025.101558_bib46","article-title":"The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study","volume":"4","author":"Galloway","year":"2020","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.jhepr.2025.101558_bib47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1055\/a-2384-6275","article-title":"Diabetes mellitus and its association with work patterns and characteristics: a narrative review","volume":"132","author":"Eleftheriou","year":"2024","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jhepr.2025.101558_bib48","unstructured":"US Census Bureau. The number of people primarily working from home tripled between 2019 and 2021. www.census.gov\/newsroom\/press-releases\/2022\/people-working-from-home.html [Accessed August 21, 2025]."},{"key":"10.1016\/j.jhepr.2025.101558_bib49","first-page":"8","article-title":"The rise in remote work since the pandemic and its impact on productivity","volume":"13","author":"Pabilonia","year":"2024","journal-title":"Beyond Numbers"},{"key":"10.1016\/j.jhepr.2025.101558_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12911-021-01403-2","article-title":"Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making","volume":"21","author":"Brnabic","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jhepr.2025.101558_bib51","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.7326\/M22-1460","article-title":"Good Publication Practice (GPP) guidelines for company-sponsored biomedical research: 2022 update","volume":"175","author":"DeTora","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhepr.2025.101558_bib52","unstructured":"American Psychological Association. Socioeconomic status. cited 2024 August 19. Available from: www.apa.org\/topics\/socioeconomic-status [Accessed August 21, 2025]."}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:12:42Z","timestamp":1762632762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592500237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S258955592500237X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101558","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world work productivity is impaired in people with metabolic dysfunction-associated steatotic liver disease in the USA","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101558"}}